Royal Fund Management, LLC Merck & Co., Inc. Transaction History

Royal Fund Management, LLC

$1.66 Billion
Q3 2024

A detailed history of Royal Fund Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Royal Fund Management, LLC holds 300 shares of MRK stock, worth $29,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 49,493 99.39%

Holding current value

$29,415

Previous $6.13 Million 99.45%

% of portfolio

0.0%

Previous 0.65%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$111.15 - $128.97 $526,851 - $611,317	4,740 Added 9.58%	54,233 $6.16 Million
Q2 2024 Jul 18, 2024	SELL	$123.8 - $132.96 $521,569 - $560,160	-4,213 Reduced 7.84%	49,493 $6.13 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $550,233 - $641,145	-4,859 Reduced 8.3%	53,706 $7.09 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $88,158 - $95,937	880 Added 1.53%	58,565 $6.38 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $3,294 - $3,658	-32 Reduced 0.06%	57,685 $5.94 Million
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $69,619 - $75,881	-641 Reduced 1.1%	57,717 $6.66 Million
Q1 2023 Apr 10, 2023	SELL	$102.94 - $114.86 $242,938 - $271,069	-2,360 Reduced 3.89%	58,358 $6.21 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $8,656 - $11,098	-99 Reduced 0.16%	60,718 $0
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $122,822 - $137,976	-1,453 Reduced 2.33%	60,817 $5.24 Million
Q2 2022 Jul 28, 2022	BUY	$83.49 - $94.64 $4,842 - $5,489	58 Added 0.09%	62,270 $5.68 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $129,965 - $145,683	-1,768 Reduced 2.76%	62,212 $5.1 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $33,104 - $41,467	-458 Reduced 0.71%	63,980 $4.9 Million
Q3 2021 Oct 20, 2021	BUY	$71.68 - $78.83 $122,429 - $134,641	1,708 Added 2.72%	64,438 $4.84 Million
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $764,691 - $845,826	10,876 Added 20.97%	62,730 $4.88 Million
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $991,515 - $1.17 Million	14,399 Added 38.44%	51,854 $4 Million
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $174,975 - $194,186	2,438 Added 6.96%	37,455 $3.06 Million
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $321,187 - $364,067	4,389 Added 14.33%	35,017 $2.9 Million
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $354,705 - $403,614	5,037 Added 19.68%	30,628 $2.37 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $1.31 Million - $1.82 Million	20,683 Added 421.41%	25,591 $1.97 Million
Q4 2019 May 11, 2020	SELL	$77.58 - $87.54 $48,487 - $54,712	-625 Reduced 11.3%	4,908 $446,000
Q3 2019 May 08, 2020	SELL	$76.08 - $82.93 $2,738 - $2,985	-36 Reduced 0.65%	5,533 $465,000
Q2 2019 May 08, 2020	SELL	$69.84 - $81.59 $29,821 - $34,838	-427 Reduced 7.12%	5,569 $466,000
Q1 2019 May 11, 2020	BUY	$69.58 - $79.36 $233,162 - $265,935	3,351 Added 126.69%	5,996 $498,000
Q4 2018 May 07, 2020	BUY	$65.24 - $75.71 $1,500 - $1,741	23 Added 0.88%	2,645 $202,000
Q3 2018 May 07, 2020	SELL	$57.69 - $67.84 $15,345 - $18,045	-266 Reduced 9.21%	2,622 $186,000
Q2 2018 May 07, 2020	SELL	$50.83 - $59.72 $65,316 - $76,740	-1,285 Reduced 30.79%	2,888 $175,000
Q1 2018 May 07, 2020	SELL	$50.96 - $59.23 $4,790 - $5,567	-94 Reduced 2.2%	4,173 $227,000
Q4 2017 May 07, 2020	SELL	$51.62 - $61.64 $6.03 Million - $7.2 Million	-116,846 Reduced 96.48%	4,267 $240,000
Q3 2017 May 07, 2020	SELL	$58.67 - $63.13 $93,050 - $100,124	-1,586 Reduced 1.29%	121,113 $7.75 Million
Q2 2017 May 07, 2020	BUY	N/A	15,517 Added 14.48%	122,699 $7.86 Million
Q1 2017 May 07, 2020	BUY	N/A	7,859 Added 7.91%	107,182 $6.81 Million
Q4 2016 May 07, 2020	BUY	N/A	99,323	99,323 $5.85 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Account

Royal Fund Management, LLC Merck & Co., Inc. Transaction History